tioridil depot 200 mg prolonged release tablet - search results

avallon pharmaceuticals pty ltd - sildenafil citrate, quantity: 35.1 mg (equivalent: sildenafil, qty 25 mg) - tablet, uncoated - excipient ingredients: indigo carmine aluminium lake; magnesium stearate; copovidone; microcrystalline cellulose; saccharin sodium; calcium hydrogen phosphate; croscarmellose sodium - noumed sildenafil is indicated for the treatment of erectile dysfunction in adult males. noumed sildenafil is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

sildenafil-drx sildenafil (as citrate) 20 mg film coated tablet blister pack

dr reddys laboratories australia pty ltd - sildenafil citrate, quantity: 28.096 mg (equivalent: sildenafil, qty 20 mg) - tablet, film coated - excipient ingredients: magnesium stearate; croscarmellose sodium; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; hyprolose; titanium dioxide; lactose monohydrate; hypromellose; triacetin; indigo carmine aluminium lake - ? to treat patients with pulmonary arterial hypertension classified as who functional classes ii and iii, to improve exercise capacity. ? efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease. ? the efficacy of sildenafil has not been evaluated in patients currently on bosentan therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

mecfil sildenafil (as citrate) 20 mg film coated tablet blister pack

dr reddys laboratories australia pty ltd - sildenafil citrate, quantity: 28.096 mg (equivalent: sildenafil, qty 20 mg) - tablet, film coated - excipient ingredients: hyprolose; croscarmellose sodium; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; triacetin; indigo carmine aluminium lake - ? to treat patients with pulmonary arterial hypertension classified as who functional classes ii and iii, to improve exercise capacity. ? efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease. ? the efficacy of sildenafil has not been evaluated in patients currently on bosentan therapy.